$893.99
-7.20[-0.80%]
At close: Apr 18
$893.99
0[0.00%]
After Hours: 4:00PM EDT
Regeneron Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Regeneron Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/02/2024 | AM | REGN | Q1 | $10.09 | $9.96 | — | — | $3.16B | $3.22B | — | — | Get Alert |
02/02/2024 | AM | REGN | Q4 | $12.56 | $10.77 | $11.86 | 10.12% | $3.41B | $3.29B | $3.43B | 4.38% | Get Alert |
11/02/2023 | AM | REGN | Q3 | $11.14 | $10.77 | $11.59 | 7.61% | $2.94B | $3.22B | $3.36B | 4.44% | Get Alert |
08/03/2023 | AM | REGN | Q2 | $9.77 | $9.92 | $10.24 | 3.23% | $2.86B | $3.01B | $3.16B | 4.92% | Get Alert |
05/04/2023 | AM | REGN | Q1 | $11.49 | $9.60 | $10.09 | 5.10% | $2.96B | $3.00B | $3.16B | 5.40% | Get Alert |
02/03/2023 | AM | REGN | Q4 | $23.42 | $10.03 | $12.56 | 25.22% | $4.95B | $3.13B | $3.41B | 9.07% | Get Alert |
11/03/2022 | AM | REGN | Q3 | $15.37 | $9.52 | $11.14 | 17.02% | $3.45B | $2.88B | $2.94B | 1.94% | Get Alert |
08/03/2022 | AM | REGN | Q2 | $25.80 | $9.54 | $9.77 | 2.41% | $5.14B | $2.79B | $2.86B | 2.40% | Get Alert |
05/04/2022 | AM | REGN | Q1 | $9.89 | $10.04 | $11.49 | 14.44% | $2.53B | $2.73B | $2.96B | 8.61% | Get Alert |
02/04/2022 | AM | REGN | Q4 | $9.53 | $18.11 | $23.72 | 30.98% | $2.42B | $4.47B | $4.95B | 10.78% | Get Alert |
11/04/2021 | AM | REGN | Q3 | $8.36 | $9.49 | $15.37 | 61.96% | $2.29B | $2.79B | $3.45B | 23.76% | Get Alert |
08/05/2021 | AM | REGN | Q2 | $7.16 | $17.69 | $25.80 | 45.85% | $1.95B | $3.89B | $5.14B | 32.11% | Get Alert |
05/06/2021 | AM | REGN | Q1 | $6.60 | $9.03 | $9.89 | 9.52% | $1.83B | $2.56B | $2.53B | -1.21% | Get Alert |
02/05/2021 | AM | REGN | Q4 | $7.50 | $8.39 | $9.53 | 13.59% | $2.17B | $2.42B | $2.42B | 0.12% | Get Alert |
11/05/2020 | AM | REGN | Q3 | $6.67 | $7.09 | $8.36 | 17.91% | $2.05B | $2.09B | $2.29B | 9.76% | Get Alert |
08/05/2020 | AM | REGN | Q2 | $6.04 | $5.98 | $7.16 | 19.73% | $1.93B | $1.74B | $1.95B | 12.18% | Get Alert |
05/05/2020 | AM | REGN | Q1 | $4.45 | $6.20 | $6.60 | 6.45% | $1.71B | $1.85B | $1.83B | -1.19% | Get Alert |
02/06/2020 | AM | REGN | Q4 | $6.84 | $6.90 | $7.50 | 8.70% | $1.93B | $2.11B | $2.17B | 2.84% | Get Alert |
11/05/2019 | AM | REGN | Q3 | $5.87 | — | $6.67 | — | $1.66B | — | $2.05B | — | Get Alert |
Regeneron Pharmaceuticals (REGN) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 2, 2024 for Q4.
The Actual EPS was $11.86, which beat the estimate of $10.77.
The Actual Revenue was $3.4B, which beat the estimate of $3.3B.
Browse earnings estimates, EPS, and revenue on all stocks.